Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 470

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 470
---
:--|-------------:|:--|:----|:--|-------------:|:--|:----|:--|-------------:|
| Balance as of January 1   |     | $ |   17,407,156 |   |     | $ |   15,705,088 |   |     | $ |   12,632,164 |
| Additions                 |     |   |      702,123 |   |     |   |    1,705,603 |   |     |   |    3,072,924 |
| Disposal                  |     |   |   (2,335,235 | ) |     |   |       (3,535 | ) |     |   |            — |
| Balance as of December 31 |     | $ |   15,774,044 |   |     | $ |   17,407,156 |   |     | $ |   15,705,088 |

F-22

APTORUM GROUP LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

12. RELATED PARTY BALANCES AND TRANSACTIONS

The following is a list of a director and related parties to which the Group has transactions with:

(a)Ian Huen, the Chief Executive Officer and Executive Director of the Group since November 2023. He was a Non-executive Director from June 2022 to November 2023. Before June 2022, he was the Chief Executive Officer and Executive Director;

(b)Jurchen Investment Corporation, the holding company and an entity controlled by Ian Huen;

(c)CGY Investment Limited, an entity owns more than % voting interest of the Group before April 2024;

(d)Aeneas Group Limited, an entity controlled by Ian Huen;

(e)Aenco Technologies Ltd, an entity being % effectively owned by Ian Huen;

(f)Aeneas Management Limited, an entity controlled by Ian Huen;

(g)Talem Medical Group Limited, an entity which Clark Cheng was a director;

(h)Libra Sciences Limited, an entity which was originally a wholly owned subsidiary of ATL. Since December 30, 2021, Libra has been turned into a related party to the Group due to the voting power owned by ATL is decreased to below % but more than %. (Note 13)

(i)ACC Medical Limited, an entity controlled by Clark Cheng, a